Feed ITMPF
Summary
28 / 100 · Bulios Score
Valuation 17Growth 78Profitability 3Quality 1Debt 69Stability 1
What speaks for it
- Revenue grew by 67% a year over the last 3 years.
- It holds more cash than debt: £197.8M against £14.7M.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (GBP)
2021202220232024202520262027
Diluted EPS (GBP)
2021202220232024202520262027
- Analyst estimate
Revenue grew by 51% a year over 5 years. Over the last 3 years it grew by 67% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of £30.8M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments £197.8M
Debt £14.7M
Free cash flow over 12 months £186.5K
Repaying all its debt would take 79.0 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.